Skip to main content

Holiday schedule

Our Patient Service Centers will be closed on Wednesday, December 25, 2024 in observance of Christmas and Wednesday, January 1, 2025 in observance of New Year's Day. Have a healthy, happy holiday.

Hide
Quest Diagnostics

Hematology

Comprehensive hematology and hematopathology solutions across the spectrum of cancer care and management

With more than 3 decades of insights and innovations in blood cancer diagnostics, we can help support your patients through every stage of their cancer journey. We offer both routine and specialized hematopathology testing services, including:

  • Comprehensive diagnostic services for blood and bone marrow biopsies with trending reports
  • Molecular assays, many of which were developed by our team at Quest Diagnostics Nichols Institute
  • Cytogenetics, including DNA microarrays
  • Flow cytometry, including specialty panels and paroxysmal nocturnal hemoglobinuria (PNH) testing
  • Reference menus for fluorescence in situ hybridization (FISH), immunohistochemistry (IHC), and special stains

A single sample is all we need to work your patient’s case, from start to finish

We offer algorithms for the diagnostic work-up of hematologic neoplasms and benign hematological disorders, including acute and chronic leukemias, lymphomas, myeloproliferative neoplasms, myelodysplastic syndromes, plasma cell neoplasms, coagulopathies, and hemoglobinopathies.

Our testing portfolio is based on clinically relevant and medically accepted guidelines, including NCCN®, WHO, ACMG, AMP, and IMWG, among others.

We offer cytogenetics, DNA/RNA, ISH, FISH, FLOW, IHC, and morphology

  • Single-gene mutational analysis
  • Quantitative PCR
  • Receptor clonality testing
  • Disease-specific panels
    –  MPN Core Diagnostic Panel
    –  LeukoVantage®
    –  AML Rapid Mutation Panel

The pathology and the testing that provides you with the most comprehensive insights

  • Bleeding profiles and screening tests
  • Von Willebrand disease
  • Factor assays and inhibitors
  • Anticoagulant therapy
  • HIT, TTP, and platelet studies
  • Fibrinolysis and markers of thrombin generation
  • Thrombotic risk markers and profiles—inherited
  • Antiphospholipid antibody and lupus anticoagulant
  • Women’s health

Medical experts and pathologists

Our experts collaborate at every step to uncover answers for every case.

Board-certified hematopathologists available for professional consultation, part of Quest Diagnostics 600+ MDs, PhDs, and world-renowned pathologists

Medical science liaisons to share key medical and scientific information to keep you up-to-date and efficient

Connecting patients and physicians to clinical trial sponsors and clinical research organizations

Make solid tumor oncology testing more actionable and accessible with our advanced solutions and enhanced services.

Learn more

Solid Tumor Cancers

Hematology

Hereditary Cancer

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.